Matinas BioPharma Holdings, Inc.
MTNB · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $10 | $5 | $3 | $2 |
| - Cash | $5 | $7 | $7 | $7 |
| + Debt | $2 | $3 | $3 | $3 |
| Enterprise Value | $7 | $1 | -$2 | -$2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$0 | -$2 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$2 | -$2 | -$4 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$5 | -$2 | -$8 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.4 | -1.03 | -0.33 | -1.73 |
| % Growth | 61.2% | -212.1% | 80.9% | – |
| Operating Cash Flow | -$1 | -$2 | -$2 | -$4 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1 | -$2 | -$2 | -$4 |